<?xml version='1.0' encoding='utf-8'?>
<document id="27023283"><sentence text="Current status and prospects of HIV treatment." /><sentence text="Current antiviral treatments can reduce HIV-associated morbidity, prolong survival, and prevent HIV transmission" /><sentence text=" Combination antiretroviral therapy (cART) containing preferably three active drugs from two or more classes is required for durable virologic suppression" /><sentence text=" Regimen selection is based on virologic efficacy, potential for adverse effects, pill burden and dosing frequency, drug-drug interaction potential, resistance test results, comorbid conditions, social status, and cost" /><sentence text=" With prolonged virologic suppression, improved clinical outcomes, and longer survival, patients will be exposed to antiretroviral agents for decades" /><sentence text=" Therefore, maximizing the safety and tolerability of cART is a high priority" /><sentence text=" Emergence of resistance and/or lack of tolerability in individual patients require availability of a range of treatment options" /><sentence text=" Development of new drugs is focused on improving safety (e" /><sentence text="g" /><sentence text=" tenofovir alafenamide) and/or resistance profile (e"><entity charOffset="1-22" id="DDI-PubMed.27023283.s10.e0" text="tenofovir alafenamide" /></sentence><sentence text="g" /><sentence text=" doravirine) within the existing drug classes, combination therapies with improved adherence (e"><entity charOffset="1-11" id="DDI-PubMed.27023283.s12.e0" text="doravirine" /></sentence><sentence text="g" /><sentence text=" single-tablet regimens), novel mechanisms of action (e" /><sentence text="g" /><sentence text=" attachment inhibitors, maturation inhibitors, broadly neutralizing antibodies), and treatment simplification with infrequent dosing (e" /><sentence text="g" /><sentence text=" long-acting injectables)" /><sentence text=" In parallel with cART innovations, research and development efforts focused on agents that target persistent HIV reservoirs may lead to prolonged drug-free remission and HIV cure" /><sentence text="" /></document>